National Institutes Of Health

Cardiovascular toxicity associated with chimeric antigen receptor T-cell therapy is both limited and reversible among high-risk children and young adults with acute lymphoblastic leukemia, according to results of a phase 1 clinical trial.

Renowned cancer researcher Steven A. Rosenberg, MD, PhD, has been awarded the 2020 Samuel D. Gross Prize for surgical research.

The NIH has awarded a $1.7 million grant to fund research into potential treatments for hereditary hemorrhagic telangiectasia, a frequently misdiagnosed but potentially life-threatening bleeding disorder.

American Association for Cancer Research today released its annual Cancer Progress Report, which outlines advances in treatment and prevention and describes how the COVID-19 pandemic has drastically altered cancer research and care.

Johnson & Johnson announced the start of a phase 3 trial that will enroll up to 60,000 people to study the safety and efficacy of its single-dose COVID-19 vaccine candidate.

The NIH this week announced the launch of Accelerating Medicine Partnership Schizophrenia, according to an institutional press release.

A collaborative global master clinical trial by The Leukemia & Lymphoma Society, Children’s Oncology Group and NCI aims to meaningfully advance the development of targeted treatments for children with acute leukemia.

Non-small cell lung cancer mortality decreased substantially among the general U.S. population between 2013 and 2016, according to results of a retrospective study published in The New England Journal of Medicine.

Donor-derived HIV superinfection “might not be a significant clinical concern” in transplants between people with HIV if the organ recipient is well monitored and virally suppressed on ART, researchers reported in The Lancet HIV.

Risks for ICU admission and death from COVID-19 are higher for adults with diabetes and hypertension, but the number of COVID-19 patients with diabetes and hypertension may be lower than previously reported.